● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

KREBSBIO

BSE
Krebs Biochemicals and Industries Limited
Healthcare· Pharmaceuticals & Biotechnology· INE268B01013· Scrip: 524518
ENहिन्दीગુજરાતીमराठी
66.00
1.75 (+0.00%)
2026-06-10
BSE
66.00
1.75
+0.00%
445771849806-1608-0710-0311-2801-2303-2005-2506-10
233 trading days · 1Y period
TODAY (BSE)
Open65.00
High69.00
Low62.90
Prev Close67.75
Volume395
Value₹0.0Cr
L: 62.90H: 69.00
Info
Face Value₹10
Listed1996-01-03
ISININE268B01013
SeriesB
BSE Scrip524518

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-10.80%
PAT-34.34%
EPS-34.46%
Profitability
TTM Revenue
₹49 Cr
TTM EBITDA
₹-13 Cr
TTM PAT
₹-25 Cr
TTM EPS
₹-11.38
Rev/Share
₹22.8

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr4 Cr7 Cr11 Cr15 Cr23-0323-0623-0923-1224-0324-0624-0924-12-3.1-2.5-1.7-2.3-2.7-2.4-2.7-3.6
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-3111 Cr19 Cr-4 Cr-8 Cr-8 Cr-3.59
2024-09-3013 Cr19 Cr-3 Cr-6 Cr-6 Cr-2.67
2024-06-3013 Cr18 Cr-3 Cr-5 Cr-5 Cr-2.40
2024-03-3112 Cr18 Cr-3 Cr-6 Cr-6 Cr-2.72
2023-12-3113 Cr18 Cr-2 Cr-5 Cr-5 Cr-2.31
2023-09-3015 Cr19 Cr-1 Cr-4 Cr-4 Cr-1.66
2023-06-3011 Cr16 Cr-4 Cr-5 Cr-5 Cr-2.47
2023-03-3111 Cr19 Cr-4 Cr-7 Cr-7 Cr-3.07

Shareholding Pattern

CURRENT2026-03-31
72.7%PROMOTER
Promoter72.7%
FII0.5%
Public27.3%
PROMOTER HOLDING TREND
72.7%24-0672.7%24-0972.7%24-1272.7%25-0372.7%25-0972.7%25-1272.7%26-03

Corporate Actions

Ex-DateTypePurpose
2023-09-20OtherAnnual General Meeting
2021-09-15Other Annual General Meeting
2020-09-16Other Annual General Meeting
2019-09-13Other Annual General Meeting
2019-01-31Rights Rights 21:100 @ Premium Rs 76 Per Share
2018-08-30Other Annual General Meeting
2017-09-14Other Annual General Meeting
2016-09-20Other Annual General Meeting
2015-09-23Other Annual General Meeting
2013-12-16OtherAnnual General Meeting
2012-09-20OtherAnnual General Meeting
2011-09-22OtherAnnual General Meeting
2010-08-16OtherAnnual General Meeting
2009-09-03OtherAnnual General Meeting
2008-09-15OtherAnnual General Meeting
2007-09-19OtherAgm Bc End Date Revised
2005-09-14DividendAgm/Dividend-30% Purpose Revised
2004-09-21DividendDividend-80%

Price History

DateOpenHighLowCloseVolume
2026-06-1067.0068.8465.7066.013,757
2026-06-0364.7866.4063.1063.902,182
2026-05-2766.9068.1465.2268.1437,417
2026-05-2664.0064.9063.0064.9017,976
2026-05-2561.7561.8160.0161.818,126
2026-05-2256.0758.8755.0058.8711,529
2026-05-2156.3957.0054.3256.071,781
2026-05-2057.9157.9155.0255.1616,230
2026-05-1956.2057.9856.2057.9147
2026-05-1857.0057.0055.5355.71902
2026-05-1556.0056.1756.0056.101,777
2026-05-1458.5559.8055.7056.563,830
2026-05-1358.0058.5558.0058.5571
2026-05-1260.0060.2058.0158.892,014
2026-05-1159.0060.0059.0060.00887
2026-05-0862.0062.3160.2060.20255
2026-05-0759.1162.9059.1162.003,952
2026-05-0660.0061.0059.0560.822,844
2026-05-0559.4060.7959.4060.791,500
2026-05-0459.3861.9959.3859.402,574
2026-04-3057.4059.8557.4059.67500
2026-04-2960.1461.0159.5060.001,915
2026-04-2857.6561.2557.6560.143,835
2026-04-2757.6059.7157.6059.522,835
2026-04-2459.4661.0059.1059.331,826
2026-04-2357.6561.2057.6559.463,061
2026-04-2261.3561.3559.3560.013,213
2026-04-2159.3862.3458.4461.504,105
2026-04-2062.0062.2659.0259.383,699
2026-04-1762.2963.0059.6562.128,155

Frequently Asked Questions

About

Krebs Biochemicals and Industries Limited is an Indian company engaged in the manufacturing and sale of active pharmaceutical ingredients. Its key products include enzymes and recombinant proteins used in the pharmaceutical and biotechnology sectors. Notably, the company was founded in 1987 and has established itself as a significant player in the domestic market.

BOARD OF DIRECTORS
Jitendra Shah
Managing Director
DEPARTED
Malati Tangirala
Independent Director
DEPARTED
Raj Kamal Prasad Verma
Independent Director
DEPARTED
Satish Khemchand Khivsara
Independent Director
DEPARTED
DEPARTED